Search Results 1051-1060 of 16254 for chemoprevention

1. A Phase 2/3 Study of Indoximod or Placebo Plus Pembrolizumab or Nivolumab in Subjects With Unresectable or Metastatic Melanoma - Mayo Clinic

   About this study. This is an adaptive clinical trial that includes a dose escalation phase followed by a randomized controlled Phase 3 trial.

2. A Study Screening Mammograms for Women in Their 40s: Mammography Choice - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

3. Breast cancer - Doctors and departments - Mayo Clinic

   Related. Breast cancer chemoprevention · Breast Cancer Education Tool · Breast cancer staging · Breast cancer types · Breast self-examination · Common questions ...

4. hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

5. A Study of Oral Sapacitabine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia - Mayo Clinic

   The two drug regimens are sapacitabine administered in alternating cycles with decitabine, or decitabine alone. The purpose of the study is to learn which drug ...

6. Mayo Clinic Comprehensive Cancer Center — Research

   Drugs used in chemotherapy, such as paclitaxel albumin-stabilized nanoparticle formulation, work in different ways to stop the growth of tumor cells, either by ...

7. Mayo Clinic Comprehensive Cancer Center — Research

   Chemotherapy drugs, such as vinorelbine, vincristine, dactinomycin, and cyclophosphamide, work in different ways to stop the growth of tumor cells, either by ...

8. Breast cancer - Doctors and departments - Mayo Clinic

   Breast cancer chemoprevention · Breast Cancer Education Tool · Breast cancer staging · Breast cancer types · Breast self-examination · Common questions about ...

9. A Study to Evaluate DS-8201a Combined with Olaparib in HER2-Expressing Cancers with Expansion in Endometrial Cancer Patients Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Endometrial Cancer - Mayo Clinic

   A Study to Evaluate DS-8201a Combined with Olaparib in HER2-Expressing Cancers with Expansion in Endometrial Cancer Patients Testing the Combination of ...

10. Overview - Translational Nanomedicine Program - Mayo Clinic Research

    The Translational Nanomedicine Program at Mayo Clinic fosters integrated development of nanoparticle theory and technology to diagnose and treat cancer.